Right after the Spring Festival, 66 industrial enterprises above designated scale in the industrial park are manufacturing in full speed for a good start at the beginning of the Lunar New Year.
Keli’s devoting to the development of industrial IOT
“Come on, hurry up, Zhang, and please carry these to the site of Project VIII.” On the first day right after the Spring Festival, the working staff and office staff are busy with relocation to the Project VIII and carrying out pre-production testing of and adjustment to the manufacturing equipment and filed environment.
As is learnt, the manufacturing factory, covering about sixty Mu, is designated for being a “Weighing Equipment Testing Center” and high-end automatic manufacturing lines for industrial IOT products. The workshop fully realizes workshop digitalization, equipment automation and management refinement, and realizes process visualization, automatic judgment of key performance parameters, remote monitoring and control of key quality control nodes through information construction.
Keli has developed a lot thanks to its contribution to the development of the industrial IOT ecology. According to the statistics, the industrial output value last year was 680 million yuan with a year-on-year increase of 11.8%.
Purebio’s upgrading for expansion of the industrial chain
Employees with Purebio Laboratories (Ningbo) Ltd. are also busy with researching, developing and manufacturing.
“We came back to work on the last day of the Spring Festival as we always do each year”, Manager Zhou with the Personnel Department told the journalist, “Many products have already been produced to be delivered to our customers throughout China”.
Purebio Laboratories (Ningbo) Ltd., a high-tech enterprise and founded in January 2007, is specialized in R&D, manufacturing, sales and service-providing for in vitro diagnostic products. For years’ development, the company now boasts 99 medical instrument registration certificates (in vitro diagnostic reagents) and the products are well sold in most cities and provinces in China and extensively applied in hospitals and third-party testing institutions.
Manager Zhou says: “Last year, 2 new wholly-owned subsidiaries were set up for R&D of biological materials and manufacturing of diagnostic instruments for expanding the company’s industrial chain and for nurturing new growth point of profit”.